2008
DOI: 10.1038/onc.2008.218
|View full text |Cite
|
Sign up to set email alerts
|

Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions

Abstract: The substrate of matrix metalloproteinase 11 (MMP11) remains unknown. We have recently shown that MMP11 is a negative regulator of adipogenesis, able to reduce and even to revert mature adipocyte differentiation. Here, we have used mouse 3T3L1 cells and human U87MG and SaOS cells to show that MMP11 cleaves the native a3 chain of collagen VI, which is an adipocyte-related extracellular matrix component. It is known that extracellular proteolytic processing of this chain is required for correct collagen VI foldi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
65
1
1

Year Published

2010
2010
2018
2018

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 100 publications
(68 citation statements)
references
References 30 publications
1
65
1
1
Order By: Relevance
“…MMP-11 is required for correct collagen VI folding and therefore for fat tissue cohesion and adipocyte function. 46 Indeed, specific proteolysis is sometimes required for correct collagen formation/folding 47 . 48 Irrespective of the mechanism, by modulating pericellular collagen composition, MMP-11 regulates matrix stiffness and can thereby influence epithelial cell behavior, as previously reported.…”
Section: Discussionmentioning
confidence: 99%
“…MMP-11 is required for correct collagen VI folding and therefore for fat tissue cohesion and adipocyte function. 46 Indeed, specific proteolysis is sometimes required for correct collagen formation/folding 47 . 48 Irrespective of the mechanism, by modulating pericellular collagen composition, MMP-11 regulates matrix stiffness and can thereby influence epithelial cell behavior, as previously reported.…”
Section: Discussionmentioning
confidence: 99%
“…It is a stromal mediator of cancer progression (8 ) that regulates the release of angiogenic factors and metastatic dissemination in experimental models (29 ). In breast cancer, MMP11 derived from cancer-associated adipocytes or fibroblastic cells exerts type VI collagenolytic activity (40 ). More recently, MMP2 has been shown to influence lymphangiogenesis through its interstitial collagenolytic activity (30 ).…”
Section: Ecm Remodelingmentioning
confidence: 99%
“…Further, MMP-11 has a weak caseinolytic activity and it has been shown to cleave insulin-like growth factor-binding protein-1 (IGF-BP-1) in a carcinoma cell line (Pei et al, 1994). Recent research has demonstrated that, although MMP-11 does not cleave many ECM proteins, degradation of type VI collagen could be physiologically related to adipogenesis inhibition (Motrescu et al, 2008).…”
Section: Structural Peculiarities and Biological Aspectsmentioning
confidence: 99%